查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1678542

北美和欧洲败血症诊断市场：市场规模、份额、趋势分析（按产品、技术、病原体、测试方法、诊断方法、最终用途和国家）、细分市场预测（2025-2030 年）

North America And Europe Sepsis Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology, By Pathogen, By Testing, By Method, By End Use, By Country, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

北美和欧洲败血症诊断市场的成长和趋势：

根据 Grand View Research, Inc. 的一份新报告，北美和欧洲败血症诊断市场规模预计到 2030 年将达到 12.4 亿美元，预测期内的复合年增长率为 7.3%。

败血症在北美十分常见，是医院死亡的主要原因。如此高的发病率推动了对有效诊断解决方案的需求。优惠的报销政策也鼓励医疗保健提供者采用先进的诊断方法，同时提高意识以及公共和私人资金正在支持创新工具的开发。

在欧洲，严格的法规确保了败血症检测的可靠性，从而支持了市场的成长。人口老化使得人们更容易感染疾病，这进一步增加了对客製化诊断解决方案的需求。此外，医疗支出的增加也提高了欧洲国家获得先进诊断服务的机会。

欧洲疾病预防控制中心 (ECDC) 在 2024 年报告称，每年约有 450 万名患者感染 HAI，主要后果是败血症。针对2023年，英国政府已拨款约1,200万美元用于抗菌素抗药性（AMR）研究，并直接支持败血症管理倡议。此外，在美国，联邦政府对败血症计画的资助预计到 2024 年将超过 5,000 万美元，目标是改善诊断技术并降低败血症相关的死亡率。

北美和欧洲败血症诊断市场报告重点：

  • 按产品划分，血液培养基将在 2023 年占据 30.0% 以上的市场占有率，而检测套件和试剂将在 2025 年至 2030 年间实现良好增长。
  • 微生物学将在 2024 年引领技术领域，预计分子诊断在预测期内将实现最快的成长，达到 9.3%。
  • 根据病原体，细菌性败血症将在 2024 年占据最大的市场占有率，这得益于死亡率的大幅上升、医院感染数量的增加以及技术的进步。预计在预测期内，其复合年增长率也将最快。
  • 根据测试技术，临床测试引领测试领域，而 POC 测试预计将以惊人的 9.6% 的复合年增长率成长。
  • 基于诊断技术，自动诊断预计在预测期内以最快的复合年增长率成长。
  • 北美败血症诊断市场由美国主导。向基于价值的护理的转变正在鼓励早期发现，而支持性报销、提高意识和政府倡议正在加强败血症管理创新。
  • 英国败血症诊断市场预计将以欧洲市场中最快的速度成长，预测期内成长率为 8.1%。
  • 2024 年 3 月，BD 与波兰 GOCC 合作，增加获得先进血流感染检测的机会，并在 150 多家医院和诊所部署最先进的微生物学设备，以改善败血症管理。

目录

第一章 分析方法及范围

第 2 章执行摘要

3. 北美和欧洲败血症诊断市场：驱动因素、趋势和范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 商业环境分析
    • 产业分析：波特五力分析
    • PESTEL 分析

4. 北美和欧洲败血症诊断市场：按产品分類的业务分析

  • 按产品市场占有率（2024 年和 2030 年）
  • 细分仪表板：依产品
  • 依产品分類的市场规模预测及趋势分析（2018-2030）
  • 装置
  • 血培养基
  • 检测试剂套件和试剂
  • 软体

5. 北美和欧洲败血症诊断市场：按技术分類的商业分析

  • 按技术分類的市场占有率（2024 年和 2030 年）
  • 细分仪表板：依技术
  • 市场规模预测及技术趋势分析（2018-2030）
  • 微生物学
  • 分子诊断
  • 免疫检测
  • 流式细胞技术
  • 其他的

6. 北美和欧洲败血症诊断市场：按病原体进行的商业分析

  • 病原体市场占有率（2024 年和 2030 年）
  • 细分仪表板：依病原体
  • 病原体市场规模预测及趋势分析（2018-2030）
  • 细菌性败血症
  • 霉菌性败血症
  • 病毒性败血症
  • 其他的

7. 北美和欧洲败血症诊断市场：按测试方法的商业分析

  • 按测试方法分類的市场占有率（2024 年和 2030 年）
  • 细分仪表板：依测试方法
  • 依测试方法分類的市场规模预测及趋势分析（2018-2030）
  • 实验室测试
  • PoC 测试

8. 北美和欧洲败血症诊断市场：按诊断方法的商业分析

  • 按诊断方法分類的市场占有率（2024 年和 2030 年）
  • 细分仪表板：按诊断
  • 诊断方法的市场规模预测及趋势分析（2018-2030年）
  • 自动诊断
  • 常规诊断

9. 北美和欧洲败血症诊断市场-按最终用途进行的商业分析

  • 按最终用途分類的市场占有率（2024 年和 2030 年）
  • 细分仪表板：依最终用途
  • 按最终用途分類的市场规模预测和趋势分析（2018-2030 年）
  • 医院和诊所
  • 病理学和参考实验室
  • 研究机构等

第 10 章 北美和欧洲败血症诊断市场：各地区估计和趋势

  • 各地区市场占有率分析（2024 年及 2030 年）
  • 市场仪表板：按地区
  • 市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 按国家/地区划分（2018-2030 年）
    • 美国
    • 加拿大
  • 欧洲
    • 按国家/地区划分（2018-2030 年）
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 挪威
    • 丹麦
    • 瑞典

第十一章 竞争格局

  • 参与企业概况
  • 公司市场地位分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • BD
    • bioMerieux SA
    • Thermo Fisher Scientific Inc.
    • Beckman Coulter, Inc.（Danaher Corporation）
    • F. Hoffmann-La Roche Ltd
    • Cepheid
    • Luminex Corp.
    • Koninklijke Philips NV
    • Bruker
    • Immunexpress Inc.
Product Code: GVR-4-68040-511-8

North America And Europe Sepsis Diagnostics Market Growth & Trends:

The North America and Europe sepsis diagnostics market size is anticipated to reach USD 1.24 billion by 2030 and is anticipated to expand at a CAGR of 7.3% during the forecast period, according to a new report by Grand View Research, Inc. North America experiences a significant prevalence of sepsis, making it a leading cause of hospital deaths. This high incidence drives the demand for effective diagnostic solutions. Favorable reimbursement policies also encourage healthcare providers to adopt advanced diagnostics, while increased awareness and public-private funding boost the development of innovative tools.

In Europe, stringent regulations ensure reliable sepsis testing methods are available, supporting market growth. The aging population, more susceptible to infections, further escalates the demand for tailored diagnostic solutions. In addition, the rising healthcare spending enhances access to advanced diagnostics across European countries.

The European Centre for Disease Prevention and Control (ECDC) reported in 2024 that HAIs affected around 4.5 million patients annually, with sepsis as a major consequence. In 2023, the UK government allocated approximately USD 12 million for antimicrobial resistance (AMR) research, directly aiding sepsis management initiatives. Moreover, projected federal funding for sepsis-related programs in the U.S. was expected to exceed USD 50 million in 2024, aimed at improving diagnostic technologies and reducing mortality rates associated with sepsis.

North America And Europe Sepsis Diagnostics Market Report Highlights:

  • Based on product, blood culture media held over 30.0% market share in 2023, while assay kits and reagents are poised for lucrative growth from 2025 to 2030 onwards
  • Microbiology led the technology segment in 2024, while molecular diagnostics are anticipated to witness the fastest rate of 9.3% over the forecast period
  • Based on pathogen, bacterial sepsis held the largest market share in 2024, driven by significant mortality rates, rising HAIs, and technological advancements. It is also expected to grow at the fastest CAGR over the forecast period
  • Based on testing, POC testing is expected to grow at a staggering 9.6% CAGR as laboratory testing led the testing segment
  • Based on method, automated diagnostic methods are expected to grow at the fastest CAGR over the forecast period
  • The U.S. dominated the North America sepsis diagnostics market as the shift to value-based care promotes early detection, while supportive reimbursement, increased awareness, and government initiatives enhance sepsis management innovations.
  • The UK sepsis diagnostics market is expected to grow at the fastest rate of 8.1% over the forecast period in the Europe market
  • In March 2024, BD collaborated with GOCC in Poland to enhance access to advanced bloodstream infection testing, deploying state-of-the-art microbiology equipment across over 150 hospitals and clinics for improved sepsis management

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
    • 1.2.3. Pathogen
    • 1.2.4. Testing
    • 1.2.5. Method
    • 1.2.6. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. North America and Europe Sepsis Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. North America and Europe Sepsis Diagnostics Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.5. Blood Culture Media
    • 4.5.1. Blood Culture Media Market, 2018 - 2030 (USD Million)
  • 4.6. Assay Kits and Reagents
    • 4.6.1. Assay Kits and Reagents Market, 2018 - 2030 (USD Million)
  • 4.7. Software
    • 4.7.1. Software Market, 2018 - 2030 (USD Million)

Chapter 5. North America and Europe Sepsis Diagnostics Market: Technology Business Analysis

  • 5.1. Technology Market Share, 2024 & 2030
  • 5.2. Technology Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 5.4. Microbiology
    • 5.4.1. Microbiology Market, 2018 - 2030 (USD Million)
  • 5.5. Molecular Diagnostics
    • 5.5.1. Molecular Diagnostics Market, 2018 - 2030 (USD Million)
    • 5.5.2. Polymerase Chain Reaction (PCR)
      • 5.5.2.1. Polymerase Chain Reaction (PCR) Market, 2018 - 2030 (USD Million)
    • 5.5.3. DNA Microarrays
      • 5.5.3.1. DNA Microarrays Market, 2018 - 2030 (USD Million)
    • 5.5.4. Syndromic Panel Testing
      • 5.5.4.1. Syndromic Panel Testing Market, 2018 - 2030 (USD Million)
    • 5.5.5. Others
      • 5.5.5.1. Others Market, 2018 - 2030 (USD Million)
  • 5.6. Immunoassays
    • 5.6.1. Immunoassays Market, 2018 - 2030 (USD Million)
  • 5.7. Flow Cytometry
    • 5.7.1. Flow Cytometry Market, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. North America and Europe Sepsis Diagnostics Market: Pathogen Business Analysis

  • 6.1. Pathogen Market Share, 2024 & 2030
  • 6.2. Pathogen Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Pathogen, 2018 to 2030 (USD Million)
  • 6.4. Bacterial Sepsis
    • 6.4.1. Bacterial Sepsis Market, 2018 - 2030 (USD Million)
    • 6.4.2. Gram-positive Bacteria
      • 6.4.2.1. Gram-positive Bacteria Market, 2018 - 2030 (USD Million)
    • 6.4.3. Gram-negative Bacteria
      • 6.4.3.1. Gram-negative Bacteria Market, 2018 - 2030 (USD Million)
  • 6.5. Fungal Sepsis
    • 6.5.1. Fungal Sepsis Market, 2018 - 2030 (USD Million)
  • 6.6. Viral Sepsis
    • 6.6.1. Viral Sepsis Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. North America and Europe Sepsis Diagnostics Market: Testing Business Analysis

  • 7.1. Testing Market Share, 2024 & 2030
  • 7.2. Testing Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Testing, 2018 to 2030 (USD Million)
  • 7.4. Laboratory Testing
    • 7.4.1. Laboratory Testing Market, 2018 - 2030 (USD Million)
  • 7.5. PoC Testing
    • 7.5.1. PoC Testing Market, 2018 - 2030 (USD Million)

Chapter 8. North America and Europe Sepsis Diagnostics Market: Method Business Analysis

  • 8.1. Method Market Share, 2024 & 2030
  • 8.2. Method Segment Dashboard
  • 8.3. Market Size & Forecasts and Trend Analysis, by Method, 2018 to 2030 (USD Million)
  • 8.4. Automated Diagnostics
    • 8.4.1. Automated Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.5. Conventional Diagnostics
    • 8.5.1. Conventional Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 9. North America and Europe Sepsis Diagnostics Market: End Use Business Analysis

  • 9.1. End Use Market Share, 2024 & 2030
  • 9.2. End Use Segment Dashboard
  • 9.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 9.4. Hospitals & Clinics
    • 9.4.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 9.5. Pathology & Reference Laboratories
    • 9.5.1. Pathology & Reference Laboratories Market, 2018 - 2030 (USD Million)
  • 9.6. Research Institutes and Others
    • 9.6.1. Research Institutes and Others Market, 2018 - 2030 (USD Million)

Chapter 10. North America and Europe Sepsis Diagnostics Market: Regional Estimates & Trend Analysis

  • 10.1. Regional Market Share Analysis, 2024 & 2030
  • 10.2. Regional Market Dashboard
  • 10.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 10.4. North America
    • 10.4.1. North America Sepsis Diagnostics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 10.4.2. U.S.
      • 10.4.2.1. Key Country Dynamics
      • 10.4.2.2. Regulatory Framework
      • 10.4.2.3. Competitive Insights
      • 10.4.2.4. U.S. Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 10.4.3. Canada
      • 10.4.3.1. Key Country Dynamics
      • 10.4.3.2. Regulatory Framework
      • 10.4.3.3. Competitive Insights
      • 10.4.3.4. Canada Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.5. Europe
    • 10.5.1. Europe Sepsis Diagnostics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 10.5.2. UK
      • 10.5.2.1. Key Country Dynamics
      • 10.5.2.2. Regulatory Framework
      • 10.5.2.3. Competitive Insights
      • 10.5.2.4. UK Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 10.5.3. Germany
      • 10.5.3.1. Key Country Dynamics
      • 10.5.3.2. Regulatory Framework
      • 10.5.3.3. Competitive Insights
      • 10.5.3.4. Germany Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 10.5.4. France
      • 10.5.4.1. Key Country Dynamics
      • 10.5.4.2. Regulatory Framework
      • 10.5.4.3. Competitive Insights
      • 10.5.4.4. France Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 10.5.5. Italy
      • 10.5.5.1. Key Country Dynamics
      • 10.5.5.2. Regulatory Framework
      • 10.5.5.3. Competitive Insights
      • 10.5.5.4. Italy Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 10.5.6. Spain
      • 10.5.6.1. Key Country Dynamics
      • 10.5.6.2. Regulatory Framework
      • 10.5.6.3. Competitive Insights
      • 10.5.6.4. Spain Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 10.5.7. Russia
      • 10.5.7.1. Key Country Dynamics
      • 10.5.7.2. Regulatory Framework
      • 10.5.7.3. Competitive Insights
      • 10.5.7.4. Russia Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 10.5.8. Norway
      • 10.5.8.1. Key Country Dynamics
      • 10.5.8.2. Regulatory Framework
      • 10.5.8.3. Competitive Insights
      • 10.5.8.4. Norway Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 10.5.9. Denmark
      • 10.5.9.1. Key Country Dynamics
      • 10.5.9.2. Regulatory Framework
      • 10.5.9.3. Competitive Insights
      • 10.5.9.4. Denmark Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 10.5.10. Sweden
      • 10.5.10.1. Key Country Dynamics
      • 10.5.10.2. Regulatory Framework
      • 10.5.10.3. Competitive Insights
      • 10.5.10.4. Sweden Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 11. Competitive Landscape

  • 11.1. Participant Overview
  • 11.2. Company Market Position Analysis
  • 11.3. Company Categorization
  • 11.4. Strategy Mapping
  • 11.5. Company Profiles/Listing
    • 11.5.1. BD
      • 11.5.1.1. Overview
      • 11.5.1.2. Financial Performance
      • 11.5.1.3. Product Benchmarking
      • 11.5.1.4. Strategic Initiatives
    • 11.5.2. bioMerieux SA
      • 11.5.2.1. Overview
      • 11.5.2.2. Financial Performance
      • 11.5.2.3. Product Benchmarking
      • 11.5.2.4. Strategic Initiatives
    • 11.5.3. Thermo Fisher Scientific Inc.
      • 11.5.3.1. Overview
      • 11.5.3.2. Financial Performance
      • 11.5.3.3. Product Benchmarking
      • 11.5.3.4. Strategic Initiatives
    • 11.5.4. Beckman Coulter, Inc. (Danaher Corporation)
      • 11.5.4.1. Overview
      • 11.5.4.2. Financial Performance
      • 11.5.4.3. Product Benchmarking
      • 11.5.4.4. Strategic Initiatives
    • 11.5.5. F. Hoffmann-La Roche Ltd
      • 11.5.5.1. Overview
      • 11.5.5.2. Financial Performance
      • 11.5.5.3. Product Benchmarking
      • 11.5.5.4. Strategic Initiatives
    • 11.5.6. Cepheid
      • 11.5.6.1. Overview
      • 11.5.6.2. Financial Performance
      • 11.5.6.3. Product Benchmarking
      • 11.5.6.4. Strategic Initiatives
    • 11.5.7. Luminex Corp.
      • 11.5.7.1. Overview
      • 11.5.7.2. Financial Performance
      • 11.5.7.3. Product Benchmarking
      • 11.5.7.4. Strategic Initiatives
    • 11.5.8. Koninklijke Philips N.V.
      • 11.5.8.1. Overview
      • 11.5.8.2. Financial Performance
      • 11.5.8.3. Product Benchmarking
      • 11.5.8.4. Strategic Initiatives
    • 11.5.9. Bruker
      • 11.5.9.1. Overview
      • 11.5.9.2. Financial Performance
      • 11.5.9.3. Product Benchmarking
      • 11.5.9.4. Strategic Initiatives
    • 11.5.10. Immunexpress Inc.
      • 11.5.10.1. Overview
      • 11.5.10.2. Financial Performance
      • 11.5.10.3. Product Benchmarking
      • 11.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. North America and Europe sepsis diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 4. North America and Europe sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 5. North America and Europe sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 6. North America and Europe sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 7. North America and Europe sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 8. North America and Europe sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 9. North America and Europe sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 10. North America sepsis diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 11. North America sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 12. North America sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 13. North America sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 14. North America sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 15. North America sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 16. North America sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 17. U.S. sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 18. U.S. sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 19. U.S. sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 20. U.S. sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 21. U.S. sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 22. U.S. sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 23. Canada sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 24. Canada sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 25. Canada sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 26. Canada sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 27. Canada sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 28. Canada sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 29. Europe sepsis diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 30. Europe sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 31. Europe sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 32. Europe sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 33. Europe sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 34. Europe sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 35. Europe sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 36. UK sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 37. UK sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 38. UK sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 39. UK sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 40. UK sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 41. UK sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 42. Germany sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 43. Germany sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 44. Germany sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 45. Germany sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 46. Germany sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 47. Germany sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 48. France sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 49. France sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 50. France sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 51. France sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 52. France sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 53. France sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 54. Italy sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 55. Italy sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 56. Italy sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 57. Italy sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 58. Italy sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 59. Italy sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 60. Spain sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 61. Spain sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 62. Spain sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 63. Spain sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 64. Spain sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 65. Spain sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 66. Russia sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 67. Russia sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 68. Russia sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 69. Russia sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 70. Russia sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 71. Russia sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 72. Denmark sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 73. Denmark sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 74. Denmark sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 75. Denmark sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 76. Denmark sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 77. Denmark sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 78. Sweden sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 79. Sweden sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 80. Sweden sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 81. Sweden sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 82. Sweden sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 83. Sweden sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 84. Norway sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 85. Norway sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 86. Norway sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 87. Norway sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 88. Norway sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 89. Norway sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 North America and Europe sepsis diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product and technology outlook (USD Million)
  • Fig. 10 Pathogen and testing outlook (USD Million)
  • Fig. 11 Method and end use outlook (USD Million)
  • Fig. 12 Competitive landscape
  • Fig. 13 North America and Europe sepsis diagnostics market dynamics
  • Fig. 14 North America and Europe sepsis diagnostics market: Porter's five forces analysis
  • Fig. 15 North America and Europe sepsis diagnostics market: PESTLE analysis
  • Fig. 16 North America and Europe sepsis diagnostics market: Product segment dashboard
  • Fig. 17 North America and Europe sepsis diagnostics market: Product market share analysis, 2024 & 2030
  • Fig. 18 Instruments market, 2018 - 2030 (USD Million)
  • Fig. 19 Blood culture media market, 2018 - 2030 (USD Million)
  • Fig. 20 Assay kits and reagents market, 2018 - 2030 (USD Million)
  • Fig. 21 Software market, 2018 - 2030 (USD Million)
  • Fig. 22 North America and Europe sepsis diagnostics market: Technology segment dashboard
  • Fig. 23 North America and Europe sepsis diagnostics market: Technology market share analysis, 2024 & 2030
  • Fig. 24 Microbiology market, 2018 - 2030 (USD Million)
  • Fig. 25 Molecular diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 26 Polymerase chain reaction (PCR) market, 2018 - 2030 (USD Million)
  • Fig. 27 DNA microarrays market, 2018 - 2030 (USD Million)
  • Fig. 28 Syndromic panel testing market, 2018 - 2030 (USD Million)
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Immunoassays market, 2018 - 2030 (USD Million)
  • Fig. 31 Flow cytometry market, 2018 - 2030 (USD Million)
  • Fig. 32 Others market, 2018 - 2030 (USD Million)
  • Fig. 33 North America and Europe sepsis diagnostics market: Pathogen segment dashboard
  • Fig. 34 North America and Europe sepsis diagnostics market: Pathogen market share analysis, 2024 & 2030
  • Fig. 35 Bacterial sepsis market, 2018 - 2030 (USD Million)
  • Fig. 36 Gram-positive bacteria market, 2018 - 2030 (USD Million)
  • Fig. 37 Gram-negative bacteria market, 2018 - 2030 (USD Million)
  • Fig. 38 Fungal sepsis market, 2018 - 2030 (USD Million)
  • Fig. 39 Viral sepsis market, 2018 - 2030 (USD Million)
  • Fig. 40 Others market, 2018 - 2030 (USD Million)
  • Fig. 41 North America and Europe sepsis diagnostics market: Testing segment dashboard
  • Fig. 42 North America and Europe sepsis diagnostics market: Testing market share analysis, 2024 & 2030
  • Fig. 43 Laboratory testing market, 2018 - 2030 (USD Million)
  • Fig. 44 PoC testing market, 2018 - 2030 (USD Million)
  • Fig. 45 North America and Europe sepsis diagnostics market: Method segment dashboard
  • Fig. 46 North America and Europe sepsis diagnostics market: Method market share analysis, 2024 & 2030
  • Fig. 47 Automated diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 48 Conventional diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 49 North America and Europe sepsis diagnostics market: End use segment dashboard
  • Fig. 50 North America and Europe sepsis diagnostics market: End use market share analysis, 2024 & 2030
  • Fig. 51 Hospitals & clinics market, 2018 - 2030 (USD Million)
  • Fig. 52 Pathology & reference laboratories market, 2018 - 2030 (USD Million)
  • Fig. 53 Research institutes and others market, 2018 - 2030 (USD Million)
  • Fig. 54 North America and Europe sepsis diagnostics market revenue, by region
  • Fig. 55 Regional marketplace: Key takeaways
  • Fig. 56 Regional marketplace: Key takeaways
  • Fig. 57 North America sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 58 U.S. country dynamics
  • Fig. 59 U.S. sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 60 Canada country dynamics
  • Fig. 61 Canada sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 62 Europe sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 63 UK country dynamics
  • Fig. 64 UK sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 65 Germany country dynamics
  • Fig. 66 Germany sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 67 France country dynamics
  • Fig. 68 France sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 69 Italy country dynamics
  • Fig. 70 Italy sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 71 Spain country dynamics
  • Fig. 72 Spain sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 73 Russia country dynamics
  • Fig. 74 Russia sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 75 Norway country dynamics
  • Fig. 76 Norway sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 77 Sweden country dynamics
  • Fig. 78 Sweden sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 79 Denmark country dynamics
  • Fig. 80 Denmark sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 81 Company categorization
  • Fig. 82 Company market position analysis
  • Fig. 83 Strategic framework